Ophthalmic Genetics Service
The Ophthalmic Genetics Service at the Casey Eye Institute is one of the premier centers in the world for patients with genetic diseases of the retina and other areas of the eye. Our internationally known doctors have considerable expertise in ophthalmic genetics. Our mission? To provide superb patient care and conduct research that will lead to effective treatments for inherited retinal degenerations.
The Oregon Retinal Degeneration Center (ORDC) is a core component of the Ophthalmic Genetics Service. The ORDC fosters the translation of basic science research into useful treatments that can be applied in the clinical setting.
We are pioneering new treatments for retinal diseases. We are currently conducting groundbreaking clinical trials in gene therapy, stem cell therapy and neuroprotective factor delivery. If you are interested in participating in a clinical trial, please contact our study coordinator Maureen Toomey at 503 494-3795.
In addition to clinical research, the ORDC’s basic science laboratory on OHSU’s Marquam Hill Campus plays a major role in bringing patients new potential treatments.
